Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03272893Completed

Biomarkers in Pain and Pain Treatment

Role: lead

NCT03344926Not ApplicableCompleted

Smart Phone ACT Treatment for Adults With Longstanding Pain - a Pilot Study

Role: lead

NCT03105908Not ApplicableCompleted

Internet-delivered ACT for Chronic Pain

Role: lead

NCT03562325Not ApplicableCompleted

ACT for ME/CFS - an Open Case Trial

Role: lead

All 4 trials loaded